Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- High Intensity Interval Training Versus Circuit Training: Complete Statistical AnalysisIndependent statistical analysis of High Intensity Interval Training Versus Circuit Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03700671).
- High MAP in Septic Shock With Hypertension: Complete Statistical AnalysisIndependent statistical analysis of High MAP in Septic Shock With Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01443494).
- High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders: Complete Statistical AnalysisIndependent statistical analysis of High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: Complete Statistical AnalysisIndependent statistical analysis of High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- High Tech and High Touch (HT2): Transforming Patient Engagement Through Portal Technology at the Bedside: Complete Statistical AnalysisIndependent statistical analysis of High Tech and High Touch (HT2): Transforming Patient Engagement Through Portal Technology at the Bedside: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- High Velocity Nasal Insufflation (Hi-VNI) Use in Upper Airway Surgery: Complete Statistical AnalysisIndependent statistical analysis of High Velocity Nasal Insufflation (Hi-VNI) Use in Upper Airway Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05090852).
- High Water Intake to Slow Progression of Polycystic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of High Water Intake to Slow Progression of Polycystic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00784030).
- High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- High-dose Bevacizumab in Advanced Renal Carcinoma Patients: Complete Statistical AnalysisIndependent statistical analysis of High-dose Bevacizumab in Advanced Renal Carcinoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00455975).
- High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors: Complete Statistical AnalysisIndependent statistical analysis of High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00936936).
- High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML: Complete Statistical AnalysisIndependent statistical analysis of High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00774046).
- High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01266603).
- High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB): Complete Statistical AnalysisIndependent statistical analysis of High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Complete Statistical AnalysisIndependent statistical analysis of High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): primary endpoint results, effect estimate with confidence interval, sample-size…
- High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00349778).
- High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- High-dose vs. Standard-dose Cephalexin for Cellulitis: Complete Statistical AnalysisIndependent statistical analysis of High-dose vs. Standard-dose Cephalexin for Cellulitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04471246).
- High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02932332).
- High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer: Complete Statistical AnalysisIndependent statistical analysis of High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- High-Intensity Interval Training to Improve Symptoms of Deployment-Related Respiratory Disease: Complete Statistical AnalysisIndependent statistical analysis of High-Intensity Interval Training to Improve Symptoms of Deployment-Related Respiratory Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05849168).
- High-Purity Type I Collagen Nerve Wrapping in Peripheral Nerve Procedures: A Prospective Registry: Complete Statistical AnalysisIndependent statistical analysis of High-Purity Type I Collagen Nerve Wrapping in Peripheral Nerve Procedures: A Prospective Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- High-Risk Skin Cancers With Atezolizumab Plus NT-I7: Complete Statistical AnalysisIndependent statistical analysis of High-Risk Skin Cancers With Atezolizumab Plus NT-I7: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03901573).
- HighdesIndependent statistical analysis of A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test: primary endpoint results, effect estimate with confidence interval, sample-size…
- Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery: primary endpoint results,…
- Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03388619).
- HIIT-BACIndependent statistical analysis of The Houston HIITBAC for African Americans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02253433).
- HIIT-SCIIndependent statistical analysis of Feasibility of HIIT in Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03152110).
- HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HIMALAYAComplete statistical analysis of the phase 3 HIMALAYA trial of durvalumab and tremelimumab in advanced hepatocellular carcinoma, including trial design, overall survival, non-inferiority methodology, Cox regression, log-rank testing, and interpretation.
- HIMALAYAIndependent statistical analysis of Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HINTIndependent statistical analysis of Developing a Health Insurance Navigation Program for Survivors of Childhood Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hip Fracture Study of GSK576428 (Fondaparinux Sodium): Complete Statistical AnalysisIndependent statistical analysis of Hip Fracture Study of GSK576428 (Fondaparinux Sodium): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00320424).
- Hip Scope Fascia-iliaca (FI) Block Study: Complete Statistical AnalysisIndependent statistical analysis of Hip Scope Fascia-iliaca (FI) Block Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02365961).
- HIP: Hip Imaging Protocol: Complete Statistical AnalysisIndependent statistical analysis of HIP: Hip Imaging Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04126161).
- HIPCVAX-010SIndependent statistical analysis of Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HIPPERIndependent statistical analysis of Feasibility of the Hip Instructional Prehabilitation Program for Enhanced Recovery (HIPPER): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HIPPOIndependent statistical analysis of Helping Improve Pediatric Patient Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03471221).
- Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Hippocampal Network Changes Following Mindfulness Training in Tobacco Vaping Adolescents in an Open-label, Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HiRTIndependent statistical analysis of Hyperglycemia in Renal Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01643382).
- Histamine Glutamate Antagonism in Stroke: Complete Statistical AnalysisIndependent statistical analysis of Histamine Glutamate Antagonism in Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02142712).
- Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast: Complete Statistical AnalysisIndependent statistical analysis of Histologic Assessment of the Difference Between 18F-2-fluoro-2-deoxy_D-glucose Positron Emission Mammography(PEM) and Magnetic Resonance Imaging (MRI) of the Breast: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Histological Comparison of Ridge Preservation Using Mineralized FDBA Alone Versus a Combined Mineralized-Demineralized Freeze Dried Bone Allograft: Complete Statistical AnalysisIndependent statistical analysis of Histological Comparison of Ridge Preservation Using Mineralized FDBA Alone Versus a Combined Mineralized-Demineralized Freeze Dried Bone Allograft: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Histopathological Evaluation of the Periodontal Ligament Subjected to Laser Ablation.: Complete Statistical AnalysisIndependent statistical analysis of Histopathological Evaluation of the Periodontal Ligament Subjected to Laser Ablation.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06173648).
- Historical Case Record Survey of Visual Acuity Data From Patients With Leber’s Hereditary Optic Neuropathy (LHON): Complete Statistical AnalysisIndependent statistical analysis of Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy: Complete Statistical AnalysisIndependent statistical analysis of Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Histrelin Subcutaneous Implant in Children With Central Precocious Puberty: Complete Statistical AnalysisIndependent statistical analysis of Histrelin Subcutaneous Implant in Children With Central Precocious Puberty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00779103).